NCT06549543

Brief Summary

The aim of this prospective, randomized, double-blinded study is to investigate the additional benefits of high-intensity laser therapy (HILT) over conventional physiotherapy, related to pain and function, in patients with knee osteoarthritis (KOA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 12, 2024

Completed
Last Updated

August 13, 2024

Status Verified

August 1, 2024

Enrollment Period

1.7 years

First QC Date

August 2, 2024

Last Update Submit

August 9, 2024

Conditions

Keywords

high-intensity laserrehabilitationpainosteoarthritis

Outcome Measures

Primary Outcomes (1)

  • The Visual Analog Scale (VAS)

    The VAS was assessed before treatment, at the end of 10 sessions, and at the 12 week follow-up. Min score was 0 and max score was 100. Higher scores on the VAS indicate greater pain.

    12 weeks

Secondary Outcomes (2)

  • Western Ontario & McMaster Universities Osteoarthritis Questionnaire (WOMAC)

    12 weeks

  • Lequesne Algofunctional Index (LAI)

    12 weeks

Study Arms (2)

High-Intensity Laser Therapy

EXPERIMENTAL

This group (n = 21) received transcutaneous electrical nerve stimulation (TENS), hotpack (HP), exercises, and high-intensity laser therapy (HILT) for 10 consecutive sessions.

Other: High Intensity Laser TherapyOther: Transcutaneous Electrical Nerve StimulationOther: Hotpacks

Control

SHAM COMPARATOR

This group (n = 22) received TENS, HP, exercises, and placebo HILT for 10 consecutive sessions.

Other: Transcutaneous Electrical Nerve StimulationOther: HotpacksOther: SHAM - High Intensity Laser Therapy

Interventions

HILT is applied per session, with a maximum of 10.0 W, a mean of 5.7 W, a dose of 99 J/cm², and a total energy flux of 2079 J were applied over 6 minutes and 5 seconds on a 21 cm² field on the medial aspect of the knee joint.

High-Intensity Laser Therapy

TENS is an analgesic modality of physical therapy

ControlHigh-Intensity Laser Therapy

Hotpacks is a thermoanalgesia modality of physical therapy

ControlHigh-Intensity Laser Therapy

for control group, sham HILT was applied, with lights on but no laser beam

Control

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • both sexes and age between 40 and 65;
  • pain at least 3 months on single or both knees
  • diagnosed as KOA with Kellgren Lawrence (KL) Grade 2 or 3 KOA on weight-bearing anteroposterior X-ray images
  • normal serum acute phase reactants and uric acid levels
  • had no major effusion in the joint.

You may not qualify if:

  • therapeutic joint injection in the last 6 months
  • physical therapy and/or HILT in the last 3 months
  • any surgical invention for the knee joint
  • malignancy in the last 5 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Başkent University Faculty of Medicine

Yüreğir, Adana, 01060, Turkey (Türkiye)

Location

Related Publications (4)

  • Akaltun MS, Altindag O, Turan N, Gursoy S, Gur A. Efficacy of high intensity laser therapy in knee osteoarthritis: a double-blind controlled randomized study. Clin Rheumatol. 2021 May;40(5):1989-1995. doi: 10.1007/s10067-020-05469-7. Epub 2020 Oct 19.

    PMID: 33074393BACKGROUND
  • Ekici B, Ordahan B. Evaluation of the effect of high-intensity laser therapy (HILT) on function, muscle strength, range of motion, pain level, and femoral cartilage thickness in knee osteoarthritis: randomized controlled study. Lasers Med Sci. 2023 Sep 25;38(1):218. doi: 10.1007/s10103-023-03887-y.

    PMID: 37743421BACKGROUND
  • Hardie EM, Carlson CS, Richardson DC. Effect of Nd:YAG laser energy on articular cartilage healing in the dog. Lasers Surg Med. 1989;9(6):595-601. doi: 10.1002/lsm.1900090610.

    PMID: 2601554BACKGROUND
  • Ahmad MA, A Hamid MS, Yusof A. Effects of low-level and high-intensity laser therapy as adjunctive to rehabilitation exercise on pain, stiffness and function in knee osteoarthritis: a systematic review and meta-analysis. Physiotherapy. 2022 Mar;114:85-95. doi: 10.1016/j.physio.2021.03.011. Epub 2021 Mar 26.

    PMID: 34654554BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneePainOsteoarthritis

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Both the participants, investigators and outcomes assessors were blinded throughout the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: patients were assigned into two groups. Both groups received conventional physiotherapy and exercise therapy. Group 1 was the experimental group, and group 2 was the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Doctor

Study Record Dates

First Submitted

August 2, 2024

First Posted

August 12, 2024

Study Start

April 1, 2022

Primary Completion

November 30, 2023

Study Completion

February 1, 2024

Last Updated

August 13, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations